Pressure Products Release: SafeSept(TM) Transseptal Guidewire Receives US FDA Market Clearance

LOS ANGELES--(BUSINESS WIRE)--Pressure Products, Inc., (www.pressure-products.com) announced today that the United States Food and Drug Administration has granted market clearance to distribute the SafeSept transseptal guidewire. This novel, patent pending device is used in conjunction with a standard Brockenbrough transseptal needle when performing a transseptal crossing in the setting of atrial fibrillation and other invasive and electrophysiological atrial bi-chamber cardiology procedures.

“The SafeSept Transseptal Guidewire, is the first significant advance in left atrial access since the invention of the Brockenbrough needle,” states Bruce N. Goldreyer, MD, Vice President and Medical Director of Pressure Products, Inc.

The SafeSept™ Transseptal Guidewire is a novel guidewire designed to easily perforate the interatrial septum, immediately become atraumatic in the left atrium, enable fluoroscopic confirmation in the pulmonary veins, and allow safer over-the-wire advancement of the transseptal needle, dilator and introducer sheath into the left atrium. SafeSept now turns the stress that accompanies every transseptal stick into a routine, “no hassles” procedure.

If you would like further information on this story, this company or its technologies, please contact Steve Cookston at steve@cookstongroup.com or view the Pressure Products Website at http://www.pressure-products.com/Pages/SafeSept_Page.html.